| scholarly article | Q13442814 |
| P50 | author | Francesca Tentori | Q91650574 |
| Ronald Pisoni | Q114400190 | ||
| P2093 | author name string | Brian D Bradbury | |
| Peter G Kerr | |||
| Bruce M Robinson | |||
| Ryan D Kilpatrick | |||
| Keith McCullough | |||
| P2860 | cites work | The renal osteodystrophy pattern in Brazil and Uruguay: an overview | Q73406489 |
| Increased risk of hip fracture among patients with end-stage renal disease | Q73969374 | ||
| Risk of hip fracture among dialysis and renal transplant recipients | Q78651051 | ||
| Towards the prevention of bone fractures in dialysed patients? | Q80031620 | ||
| Progression of vascular calcifications is associated with greater bone loss and increased bone fractures | Q80461984 | ||
| Increased risk of mortality associated with hip fracture in the dialysis population | Q80598163 | ||
| Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus | Q81364249 | ||
| Early readmission and length of hospitalization practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS) | Q83687853 | ||
| The DOPPS Practice Monitor for US dialysis care: trends through December 2011 | Q85363908 | ||
| Foreword | Q95783787 | ||
| The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology | Q30970415 | ||
| A systematic review of hip fracture incidence and probability of fracture worldwide | Q34261509 | ||
| Vascular calcification and inorganic phosphate | Q34384685 | ||
| Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. | Q34659177 | ||
| Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon | Q34986029 | ||
| KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). | Q34994912 | ||
| Estimating hip fracture morbidity, mortality and costs | Q35067155 | ||
| Mortality and morbidity after hip fractures | Q35190430 | ||
| The prevention and treatment of osteoporosis | Q36367030 | ||
| Vascular calcifications, vertebral fractures and mortality in haemodialysis patients | Q37090796 | ||
| Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis | Q44543512 | ||
| The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population | Q44643763 | ||
| Rate of mortality for elderly patients after fracture of the hip in the 1980's | Q45285200 | ||
| Mortality following fractures in older women. The study of osteoporotic fractures | Q46389938 | ||
| Aortic calcification and the risk of osteoporosis and fractures | Q46548686 | ||
| Pulmonary infectious mortality among patients with end-stage renal disease. | Q50688489 | ||
| Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. | Q51789429 | ||
| Cortical pQCT measures are associated with fractures in dialysis patients. | Q53543744 | ||
| PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. | Q53607251 | ||
| Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone | Q73235636 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone fracture | Q68833 |
| patient | Q181600 | ||
| hospitalization | Q3140971 | ||
| hemodialysis patient | Q126109077 | ||
| P304 | page(s) | 166-173 | |
| P577 | publication date | 2013-07-31 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | High rates of death and hospitalization follow bone fracture among hemodialysis patients. | |
| P478 | volume | 85 |
| Q92346687 | 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report |
| Q52722043 | A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro. |
| Q57771661 | Alkaline phosphatase: Better than PTH as a marker of cardiovascular and bone disease? |
| Q91608643 | Assessment of CYP-Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in Humans |
| Q36129934 | Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis |
| Q56964890 | Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients |
| Q39254025 | Biomarkers Predicting Bone Turnover in the Setting of CKD. |
| Q38958627 | Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. |
| Q38579166 | Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management |
| Q30234636 | Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics. |
| Q47738927 | Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. |
| Q90328403 | Bone biopsy in nephrology practice |
| Q40275241 | Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper |
| Q90305128 | Bone fragility in patients with chronic kidney diseases |
| Q47248898 | Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting? |
| Q41625862 | Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. |
| Q38240989 | Calcium supplementation in chronic kidney disease |
| Q26997002 | Can one evaluate bone disease in chronic kidney disease without a biopsy? |
| Q38678632 | Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient |
| Q37639872 | Chronic kidney disease and fragility fracture |
| Q38565049 | Cinacalcet and Clinical Outcomes in Dialysis |
| Q38784139 | Clinical features of CKD-MBD in Japan: cohort studies and registry |
| Q49670897 | Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures |
| Q36281399 | Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture |
| Q40296289 | Dementia is a major risk factor for hip fractures in patients with chronic kidney disease |
| Q41622523 | Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study |
| Q58578153 | Dialysis Prescription and Sudden Death |
| Q35658608 | Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial |
| Q91817150 | Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia |
| Q38797594 | Emerging role of high-resolution imaging in the detection of renal osteodystrophy. |
| Q39225909 | Evaluation of fracture risk in chronic kidney disease. |
| Q87850998 | Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis |
| Q30703135 | Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study |
| Q64989241 | Fracture Risk in Dialysis and Kidney Transplanted Patients: A Systematic Review. |
| Q46275115 | Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis. |
| Q62002776 | Fractures in chronic kidney disease: neglected, common, and associated with sickness and death |
| Q85208488 | High rates of death and hospitalization follow bone fracture among hemodialysis patients |
| Q33608339 | High short-term and long-term excess mortality in geriatric patients after hip fracture: a prospective cohort study in Taiwan |
| Q53830343 | Hip fracture incidence and mortality in chronic kidney disease: the GLOMMS-II record linkage cohort study. |
| Q93089365 | Hip hemiarthroplasty for femoral neck fractures in end-stage renal disease patients on dialysis compared to patients with late-stage chronic kidney disease |
| Q35392994 | Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study. |
| Q37418997 | Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism |
| Q52674795 | Is there a practical role for a virtual bone biopsy using high-resolution imaging of bone in patients with chronic kidney disease? |
| Q48207264 | Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis. |
| Q38775426 | Management of secondary hyperparathyroidism: how and why? |
| Q30234751 | Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. |
| Q35684700 | Mortality and complications after hip fracture among elderly patients undergoing hemodialysis |
| Q33749240 | Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake. |
| Q53397196 | Noninvasive Imaging of Bone Microarchitecture in Patients Receiving Renal Transplant: Can it Replace Histology? |
| Q49166621 | Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes |
| Q39255870 | Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. |
| Q97530990 | Osteoporotic fracture rates in chronic hemodialysis and effect of heparin exposure: a retrospective cohort study |
| Q38771730 | Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease |
| Q35945202 | Outcomes following surgery for fractured neck of femur in dialysis patients: a 5-year review from a district general hospital in the United Kingdom |
| Q36072533 | Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients |
| Q99413317 | Reversing cortical porosity: Cortical pore infilling in preclinical models of chronic kidney disease |
| Q39758072 | Risk of fracture in adults on renal replacement therapy: a Danish national cohort study |
| Q39618928 | Safety and efficacy of denosumab in osteoporotic hemodialysed patients |
| Q38530298 | Sclerostin and DKK1: new players in renal bone and vascular disease |
| Q38872880 | Self-Reported Employment Status and Social Participation After Successful Kidney Transplantation |
| Q39249486 | The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey |
| Q41408549 | The FRAX ® as a predictor of mortality in Japanese incident hemodialysis patients: an observational, follow-up study |
| Q41957424 | The influence of renal dialysis and hip fracture sites on the 10-year mortality of elderly hip fracture patients: A nationwide population-based observational study. |
| Q50124946 | The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease |
| Q49375971 | Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors |
| Q48197934 | Update on the role of bone biopsy in the management of patients with CKD-MBD. |
| Q39345412 | Uremic Toxicity and Bone in CKD. |
| Q47109433 | Vitamin K and bone |
| Q58129371 | [Value of serum alkaline phosphatase for predicting 2-year fracture in patients with chronic kidney disease on dialysis] |
Search more.